Clobazam Patent Expiration
Clobazam is Used for managing seizure disorders. It was first introduced by Lundbeck Pharmaceuticals Llc
Clobazam Patents
Given below is the list of patents protecting Clobazam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sympazan | US11541002 | Oral film compositions and dosage forms having precise active dissolution profiles | Jan 31, 2040 | Otter Pharms |
| Sympazan | US8603514 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr 03, 2024
(Expired) | Otter Pharms |
| Sympazan | US8765167 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb 20, 2024
(Expired) | Otter Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Clobazam's patents.
Latest Legal Activities on Clobazam's Patents
Given below is the list recent legal activities going on the following patents of Clobazam.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical
| 03 Jan, 2023 | US11541002 |
| Recordation of Patent Grant Mailed Critical
| 03 Jan, 2023 | US11541002 |
| Issue Notification Mailed Critical
| 14 Dec, 2022 | US11541002 |
| Application Is Considered Ready for Issue Critical
| 29 Nov, 2022 | US11541002 |
| Dispatch to FDC | 29 Nov, 2022 | US11541002 |
| Workflow - Drawings Finished | 28 Nov, 2022 | US11541002 |
| PUB Other miscellaneous communication to applicant | 03 Nov, 2022 | US11541002 |
| Mail PUB other miscellaneous communication to applicant | 03 Nov, 2022 | US11541002 |
| Issue Fee Payment Received Critical
| 27 Oct, 2022 | US11541002 |
| Issue Fee Payment Verified Critical
| 27 Oct, 2022 | US11541002 |
Clobazam's Family Patents
